Trial intelligence / Profile preview

Yiqifumai freeze-dried injection for sepsis with qi-yin deficiency

ChiCTR2200057075Phase 4Not yet recruiting

Sponsor
Xiyuan Hospital
Start
Oct 2021
Countries
1
01

Overview

Phase 4, randomised, single-blind trial of yiqi fumai in sepsis (2 arms), sponsored by Xiyuan Hospital. Primary endpoints: Death rate, Length of ICU stay and 4 more. Planned start Oct 2021; status: not yet recruiting.

02

Drugs

yiqi fumai
03

Conditions

sepsis

Beyond the preview

Go deeper on ChiCTR2200057075.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200057075.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call